Press release
Next-Gen Data Access for Pharma: How Integrated Data Ecosystems Are Powering Global Pharma Decision-Making | Thelansis Case Study
Next-Gen Data Access for Pharma: How Integrated Data Ecosystems Are Powering Global Pharma Decision-Making | Thelansis Case Study
In today's dynamic pharmaceutical landscape, the need for seamless data access and faster decision-making has made AI-powered, cloud-based solutions a cornerstone of innovation. As a pharma company that works across multiple therapy areas simultaneously, traditional data silos have proven inefficient for providing insights into country-specific disease burden, epidemiology research, and, essentially, market forecasts. To address these challenges, Thelansis developed an AI-enabled cloud platform that transforms how organizations access, analyze, and apply epidemiology and market insights. This case study explores how Thelansis partnered with a global biopharma client to streamline their research processes.
Discover how our integrated data ecosystems are transforming global biopharmaceutical strategy and accelerating research outcomes, visit us: https://thelansis.com/
Objective:
A client with a diverse product portfolio sought a centralized, scalable, and Competitive Intelligence system to access reliable epidemiology and disease landscape insights. Our team collaborated with theirs to understand their requirements, based on the product pipeline, lifecycle management priorities, and future interests. Our primary goal was to simplify access to epidemiology and market forecasts across multiple therapeutic areas and geographies, enabling them to support their needs with real-time, high-quality insights.
Approach:
We further customized our proprietary AI-enabled cloud platform, transforming data into a user-friendly technology, and provided access to epidemiology and landscape insights for all prioritized indications. The platform offered intuitive dashboards, data visualization, and exportable reports, ensuring easy integration with the client's internal systems.
During demo sessions, our team showcased the depth and breadth of epidemiology coverage at a global level, including prevalence, incidence, demographic distributions, severity-wise distribution, diagnosis, prognosis, treatment utilization, patient journey, and emerging therapy.
In the pilot phase, the client's teams accessed the platform to get real-time research insights. They mentioned that this tool helped them save a significant amount of time and provided 24/7 analyst-like support to address queries, ensuring seamless adoption and confidence in data quality.
To explore our diverse capabilities across multiple indications, alongside our recognized expertise in rare and ultra-rare diseases and customized reporting solutions, discover the extensive report library available @ https://thelansis.com/reports/
Outcome:
60% reduction in time spent gathering and validating disease area landscape data
Enhanced decision-making through consistent, validated, and high-quality datasets with visual analytics
5X times faster data processing and report generation
To receive personalized expert insights tailored to your organization's specific requirements, you can connect directly with our consultant: clientsupport@thelansis.com
CONTACT:
Himanshi Negi
Manager - Global BD and Partnering
Thelansis Knowledge Partners LLP
Email: n.himanshi@thelansis.com
Phone: +91-9560149525
Website: www.thelansis.com
Reach us at: clientsupport@thelansis.com
ABOUT THELANSIS:
Thelansis is a global healthcare market intelligence company providing strategic insights to global pharmaceutical, biotechnology, and life sciences organizations. Through proprietary epidemiology models, primary research, physician interviews, payer analysis, and commercial forecasting, Thelansis enables organizations to make informed decisions across product development, market access, and commercialization.
In addition, Thelansis offers EpiLansis, an AI-powered cloud intelligence platform that enables interactive exploration of patient populations, epidemiology trends, treatment utilization, and market dynamics across multiple therapeutic areas.
For more information about Thelansis and its disease intelligence solutions, visit www.thelansis.com or contact the team at clientsupport@thelansis.com.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Next-Gen Data Access for Pharma: How Integrated Data Ecosystems Are Powering Global Pharma Decision-Making | Thelansis Case Study here
News-ID: 4582750 • Views: …
More Releases from THELANSIS KNOWLEDGE PARTNERS LLP
Tourette Syndrome Pipeline Shift: What Thelansis Data Reveals on the D1-Antagoni …
Tourette Syndrome (TS) has gone decades without a therapy purpose-built for it, every approved option today is a repurposed antipsychotic or alpha agonist. That is finally changing in 2026, and the shift is forcing companies across the CNS space to rethink where the real commercial opportunity in TS sits: not just in efficacy, but in tolerability, patient segmentation, and how well a molecule maps to what physicians and caregivers actually…
Fabry Disease in 2026: Emerging Therapies, Persistent Unmet Needs, and the Evolv …
Rare disease drug development is entering a transformative phase, and Fabry disease stands among the indications witnessing significant innovation. While enzyme replacement therapy (ERT) and oral chaperone therapy have improved disease management over the past two decades, they have not fully addressed the challenges of long-term disease progression, organ preservation, treatment burden, or genetic heterogeneity. As a result, the next generation of therapies is increasingly focused on delivering durable clinical…
Generalized Pustular Psoriasis Market Set to Transform as IL-36 Targeted Therapi …
Thelansis releases an in-depth "Generalized Pustular Psoriasis (GPP) Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report (2026-2036)," mapping how rapid-onset biologics, an FDA decision due later this year, and rising diagnostic awareness are set to redefine care for this rare, life-threatening skin disease across the US, EU5, Japan, and China.
Generalized Pustular Psoriasis is having a moment. For decades, this rare and potentially fatal autoinflammatory skin disorder had no dedicated…
Pulmonary Arterial Hypertension Market Poised for Steady Growth Through 2036 Ami …
The Pulmonary Arterial Hypertension (PAH) treatment landscape is entering one of its most active periods in over a decade. With a wave of late-breaking clinical data unveiled at major pulmonology conferences in 2026, an expanding pipeline of oral and biologic therapies, and growing physician confidence in disease-modifying approaches, PAH is shifting from a purely symptom-management model toward long-term risk reduction.
A newly published report, Pulmonary Arterial Hypertension (PAH) Market Outlook,…
More Releases for Data
Data Catalog Market: Serving Data Consumers
Data Catalog Market size was valued at US$ 801.10 Mn. in 2022 and the total revenue is expected to grow at a CAGR of 23.2% from 2023 to 2029, reaching nearly US$ 3451.16 Mn.
Data Catalog Market Report Scope and Research Methodology
The Data Catalog Market is poised to reach a valuation of US$ 3451.16 million by 2029. A data catalog serves as an organized inventory of an organization's data assets, leveraging…
Big Data Security: Increasing Data Volume and Data Velocity
Big data security is a term used to describe the security of data that is too large or complex to be managed using traditional security methods. Big data security is a growing concern for organizations as the amount of data generated continues to increase. There are a number of challenges associated with securing big data, including the need to store and process data in a secure manner, the need to…
HOW TO TRANSFORM BIG DATA TO SMART DATA USING DATA ENGINEERING?
We are at the cross-roads of a universe that is composed of actors, entities and use-cases; along with the associated data relationships across zillions of business scenarios. Organizations must derive the most out of data, and modern AI platforms can help businesses in this direction. These help ideally turn Big Data into plug-and-play pieces of information that are being widely known as Smart Data.
Specialized components backed up by AI and…
Test Data Management (TDM) Market - test data profiling, test data planning, tes …
The report categorizes the global Test Data Management (TDM) market by top players/brands, region, type, end user, market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
This report studies the global market size of Test Data Management (TDM) in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption…
Data Prep Market Report 2018: Segmentation by Platform (Self-Service Data Prep, …
Global Data Prep market research report provides company profile for Alteryx, Inc. (U.S.), Informatica (U.S.), International Business Corporation (U.S.), TIBCO Software, Inc. (U.S.), Microsoft Corporation (U.S.), SAS Institute (U.S.), Datawatch Corporation (U.S.), Tableau Software, Inc. (U.S.) and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY…
Long Term Data Retention Solutions Market - The Increasing Demand For Big Data W …
Data retention is a technique to store the database of the organization for the future. An organization may retain data for several different reasons. One of the reasons is to act in accordance with state and federal regulations, i.e. information that may be considered old or irrelevant for internal use may need to be retained to comply with the laws of a particular jurisdiction or industry. Another reason is to…
